Introduction: Basic Biology of the Renal Endothelin System

Seminars in Nephrology

Volumn 35, Issue 2, 2015, Pages 121-124

  Kohan, Donald E ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR;

AUTOCRINE EFFECT; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; DRUG PROTEIN BINDING; EDITORIAL; ENDOCYTOSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NEPHROLOGY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; KIDNEY CIRCULATION; MOLECULAR BIOLOGY; PHYSIOLOGY;

ENDOTHELINS; HUMANS; MOLECULAR BIOLOGY; RENAL CIRCULATION;

EID: 84929049165     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2015.02.001     Document Type: Editorial

References (34)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
2. Kohan D.E., Rossi N.F., Inscho E.W., Pollock D.M. Regulation of blood pressure and salt homeostasis by endothelin. Physiological Rev 2011, 91:1-77.
3. Barton M. Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. Biochim Biophys Acta 2010, 1802:1203-1213.
4. Kohan D.E., Barton M. Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int 2014, 86:896-904.
5. Inoue A., Yanagisawa M., Takuwa Y., Mitsui Y., Kobayashi M., Masaki T. The human preproendothelin-1 gene. J Biol Chem 1989, 264:14954-14959.
6. Masaki T., Kimura S., Yanagisawa M., Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991, 84:1457-1468.
7. Blais V., Fugere M., Denault J.B., Klarskov K., Day R., Leduc R. Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family. FEBS Lett 2002, 524:43-48.
8. D'Orleans-Juste P., Plante M., Honore J.C., Carrier E., Labonte J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol 2003, 81:503-510.
9. Turner A.J., Murphy L.J. Molecular pharmacology of endothelin converting enzymes. Biochem Pharm 1996, 51:91-102.
10. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 2004, 25:219-224.
11. Yanagisawa H., Hammer R.E., Richardson J.A., Emoto N., Williams S.C., Takeda S.-i., et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 2000, 105:925-933.
12. Harrison V.J., Barnes K., Turner A.J., Wood E., Corder R., Vane J.R. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci 1995, 92:6344-6348.
13. Russell F.D., Davenport A.P. Secretory pathways in endothelin synthesis. Br J Pharmacol 1999, 126:391-398.
14. Russell F.D., Skepper J.N., Davenport A.P. Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 1998, 83:314-321.
15. Opgenorth T.J., Wessale J.L., Dixon D.B., Adler A.L., Calzadilla S.V., Padley R.J., et al. Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. J Cardiovasc Pharmacol 2000, 36:S292-S296.
16. Strachan F.E., Spratt J.C., Wilkinson I.B., Johnston N.R., Gray G.A., Webb D.J. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 1999, 33:581-585.
17. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994, 199:1461-1465.
18. Loffler B.M., Breu V., Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 1993, 333:108-110.
19. Vijayaraghavan J., Scicli A.G., Carretero O.A., Slaughter C., Moomaw C., Hersh L.B. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990, 265:14150-14155.
20. Itoh K., Kase R., Shimmoto M., Satake A., Sakuraba H., Suzuki Y. Protective protein as an endogenous endothelin degradation enzyme in human tissues. J Biol Chem 1995, 270:515-518.
21. Jackman H.L., Morris P.W., Deddish P.A., Skidgel R.A., Erdos E.G. Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem 1992, 267:2872-2875.
22. Kohno M., Murakawa K., Yasunari K., Yokokawa K., Horio T., Kurihara N., et al. Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats. Metabolism 1989, 38:712-713.
23. Abassi Z.A., Tate J.E., Golomb E., Keiser H.R. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992, 20:89-95.
24. Hosoda K., Nakao K., Tamura N., Arai H., Ogawa Y., Suga S., et al. Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 1992, 267:18797-18804.
25. Sakamoto A., Yanagisawa M., Sakurai T., Takuwa Y., Yanagisawa H., Masaki T. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun 1991, 178:656-663.
26. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990, 348:730-732.
27. Sorokin A., Kohan D.E. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 2003, 285:F579-F589.
28. Gregan B., Jurgensen J., Papsdorf G., Furkert J., Schaefer M., Beyermann M., et al. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 2004, 279:27679-27687.
29. Evans N.J., Walker J.W. Sustained Ca2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger. Can J Physiol Pharmacol 2008, 86:526-535.
30. Waggoner W.G., Genova S.L., Rash V.A. Kinetic analyses demonstrate that the equilibrium assumption does not apply to [125I]endothelin-1 binding data. Life Sci 1992, 51:1869-1876.
31. Wu-Wong J.R., Chiou W.J., Magnuson S.R., Opgenorth T.J. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim Biophys Acta 1994, 1224:288-294.
32. Chun M., Lin H.Y., Henis Y.I., Lodish H.F. Endothelin-induced endocytosis of cell surface ETA receptors. J Biol Chem 1995, 270:10855-10860.
33. Bremnes T., Paasche J.D., Mehlum A., Sandberg C., Bremnes B., Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 2000, 275:17596-17604.
34. Kohan D.E., Padilla E. Endothelin-1 is an autocrine factor in rat inner medullary collecting ducts. Am J Physiol 1992, 263:F607-F612.